Your browser doesn't support javascript.
loading
Nonclinical safety assessment of Efinaconazole Solution (10%) for onychomycosis treatment.
Jo, William; Glynn, Marian; Nejishima, Hiroaki; Sanada, Hisakazu; Minowa, Kenji; Calvarese, Barry; Senda, Hisato; Pillai, Radhakrishnan; Mutter, Linda.
  • Jo W; Dow Pharmaceutical Sciences, A Division of Valeant Pharmaceuticals International, 1330 Redwood Way, Petaluma, CA 94954, USA. Electronic address: wjo@dowpharmsci.com.
  • Glynn M; Dow Pharmaceutical Sciences, A Division of Valeant Pharmaceuticals International, 1330 Redwood Way, Petaluma, CA 94954, USA.
  • Nejishima H; Kaken Pharmaceutical Co., Ltd., 301, Gensuke, Fujieda, Shizuoka, Japan.
  • Sanada H; Kaken Pharmaceutical Co., Ltd., 301, Gensuke, Fujieda, Shizuoka, Japan.
  • Minowa K; Kaken Pharmaceutical Co., Ltd., 301, Gensuke, Fujieda, Shizuoka, Japan.
  • Calvarese B; Dow Pharmaceutical Sciences, A Division of Valeant Pharmaceuticals International, 1330 Redwood Way, Petaluma, CA 94954, USA.
  • Senda H; Kaken Pharmaceutical Co., Ltd., 301, Gensuke, Fujieda, Shizuoka, Japan.
  • Pillai R; Dow Pharmaceutical Sciences, A Division of Valeant Pharmaceuticals International, 1330 Redwood Way, Petaluma, CA 94954, USA.
  • Mutter L; Dow Pharmaceutical Sciences, A Division of Valeant Pharmaceuticals International, 1330 Redwood Way, Petaluma, CA 94954, USA.
Regul Toxicol Pharmacol ; 70(1): 242-53, 2014 Oct.
Article en En | MEDLINE | ID: mdl-25038564

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Piel / Triazoles / Onicomicosis / Antifúngicos Límite: Animals Idioma: En Año: 2014 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Piel / Triazoles / Onicomicosis / Antifúngicos Límite: Animals Idioma: En Año: 2014 Tipo del documento: Article